Smithson W A, Perrault J
Mayo Clin Proc. 1982 May;57(5):322-5.
A 12-year-old girl with congenital dyserythropoietic anemia, type I, was diagnosed as having hemochromatosis. Deferoxamine was given subcutaneously for 14 months. Iron overload, as measured by liver iron and serum ferritin levels, was reduced substantially, liver function tests improved, and hepatomegaly decreased. Toxicity was negligible.
一名12岁患有I型先天性红细胞生成异常性贫血的女孩被诊断为血色素沉着症。皮下注射去铁胺14个月。通过肝脏铁含量和血清铁蛋白水平测定的铁过载显著降低，肝功能检查改善，肝肿大减轻。毒性可忽略不计。
